Accuvest Global Advisors’s Labcorp LH Stock Holding History

Accuvest Global Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,508	Closed	-$272K	–	121
2018 Q4	$272K	Buy	+2,508	New	+$336K	0.14%	102

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Accuvest Global Advisors's LH Position: Q1 2019 in Review

Accuvest Global Advisors sold out of Labcorp (LH) in Q1 2019, closing a stake of 2,508 shares — an estimated $272K sold.

Accuvest Global Advisors first reported a position in LH in Q4 2018 and held it in 1 quarter. The position peaked at $272K in Q4 2018. 744 funds tracked by Wall St. Rank hold LH as of Q1 2019.

Accuvest Global Advisors reported no remaining Labcorp position as of Q1 2019 after selling out during the quarter.
Accuvest Global Advisors sold 2,508 Labcorp shares in Q1 2019, an estimated $272K.
Accuvest Global Advisors first reported a position in Labcorp in Q4 2018 and held it in 1 quarter.
Accuvest Global Advisors's Labcorp position peaked at $272K in Q4 2018.
744 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on Accuvest Global Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.